Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

BUY
$209.01 - $232.56 $67,301 - $74,884
322 Added 1.28%
25,405 $5.55 Billion
Q4 2023

Feb 13, 2024

BUY
$197.69 - $227.29 $780,084 - $896,886
3,946 Added 18.67%
25,083 $5.7 Billion
Q3 2023

Nov 14, 2023

BUY
$201.05 - $221.7 $162,649 - $179,355
809 Added 3.98%
21,137 $4.25 Billion
Q2 2023

Aug 11, 2023

BUY
$211.93 - $241.33 $1.46 Million - $1.67 Million
6,905 Added 51.44%
20,328 $4.91 Billion
Q1 2023

May 12, 2023

BUY
$213.32 - $257.83 $2.86 Million - $3.46 Million
13,423 New
13,423 $3.08 Billion

Others Institutions Holding LH

About LABORATORY CORP OF AMERICA HOLDINGS


  • Ticker LH
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 89,600,000
  • Market Cap $22.1B
  • Description
  • Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...
More about LH
Track This Portfolio

Track Ostrum Asset Management Portfolio

Follow Ostrum Asset Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ostrum Asset Management, based on Form 13F filings with the SEC.

News

Stay updated on Ostrum Asset Management with notifications on news.